CLB · NYSE
Core Laboratories (CLB) Stock Price & Fundamentals
Core Laboratories (CLB) closed at $1,012.37 on Oct 9, 2026, down 0.56% from the previous close of $1,018.11.
Share price, past year
1Y −12.72%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,012.37 |
| Sep 30, 2026 | $1,011.48 |
| Aug 31, 2026 | $937.00 |
| Jul 31, 2026 | $900.29 |
| Jun 30, 2026 | $900.42 |
| May 29, 2026 | $959.59 |
| Apr 30, 2026 | $994.63 |
| Mar 31, 2026 | $1,055.19 |
| Feb 27, 2026 | $1,051.81 |
| Jan 30, 2026 | $1,078.12 |
| Dec 31, 2025 | $1,072.94 |
| Nov 28, 2025 | $1,044.15 |
| Oct 31, 2025 | $1,107.15 |
Key statistics
- Market cap
- $46.45B
- P/E (TTM)
- 1,946.9
- EPS (TTM)
- $0.52
- Revenue (TTM)
- $519.18M
- Net income (TTM)
- $24.35M
- Shares outstanding
- 45.9M
- Dividend yield
- —
- 52-week range
- $878.31 – $1,165.71
Core Laboratories's market cap is $46.45B, based on a share price of $1,012.37 and 45.9M shares outstanding as of Jun 30, 2026.
Financials
Core Laboratories reported revenue of $526.52M for fiscal 2025, up 0.51% from fiscal 2024.
Core Laboratories earned net income of $29.67M in fiscal 2025, a net margin of 5.6%.
Fiscal 2025 revenue was the highest in the 5 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $526.52M | +0.5% | $29.67M | 5.6% | $0.63 | $25.82M |
| FY2024ended Dec 31, 2024 | $523.85M | +2.8% | $31.40M | 6.0% | $0.66 | $44.50M |
| FY2023ended Dec 31, 2023 | $509.79M | +4.1% | $36.68M | 7.2% | $0.77 | $14.21M |
| FY2022ended Dec 31, 2022 | $489.74M | +4.1% | $19.45M | 4.0% | $0.42 | $14.74M |
| FY2021ended Dec 31, 2021 | $470.25M | — | $19.73M | 4.2% | $0.42 | $23.04M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $124.61M | $5.96M | $0.13 |
| Q1 FY2026ended Mar 31, 2026 | $121.80M | −$789.00K | −$0.02 |
| Q4 FY2025ended Dec 31, 2025 | $138.26M | $4.95M | $0.11 |
| Q3 FY2025ended Sep 30, 2025 | $134.52M | $14.24M | $0.30 |
| Q2 FY2025ended Jun 30, 2025 | $130.16M | $10.64M | $0.22 |
| Q1 FY2025ended Mar 31, 2025 | $123.59M | −$154.00K | $0.00 |
| Q4 FY2024ended Dec 31, 2024 | $129.24M | $7.40M | $0.15 |
| Q3 FY2024ended Sep 30, 2024 | $134.40M | $11.75M | $0.25 |
Company profile
- Name
- Core Laboratories Inc. /DE/
- Ticker
- CLB
- Exchange
- NYSE
- Industry (SEC SIC)
- Oil & Gas Field Services, NEC
- Headquarters
- 6316 Windfern Road, Houston, TX 77040
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001958086
Recent SEC filings
- Aug 25, 2026
- Jul 30, 2026
- Jul 29, 2026
- May 13, 2026
- May 1, 2026
- Apr 29, 2026
- Mar 23, 2026
- Mar 23, 2026
Frequently asked questions
What is Core Laboratories's stock price?
Core Laboratories (CLB) closed at $1,012.37 on Oct 9, 2026, down 0.56% from the previous close of $1,018.11.
What is Core Laboratories's market cap?
Core Laboratories's market cap is $46.45B, based on a share price of $1,012.37 and 45.9M shares outstanding as of Jun 30, 2026.
How much revenue does Core Laboratories make?
Core Laboratories reported revenue of $526.52M for fiscal 2025, up 0.51% from fiscal 2024.
What is CLB's P/E ratio?
Core Laboratories's price-to-earnings ratio is 1,946.9, based on trailing twelve-month diluted EPS of $0.52.
Does Core Laboratories pay a dividend?
Core Laboratories's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Core Laboratories Inc. /DE/'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures